CKD-828 (40/5mg) Pharmacokinetic Study

NCT01340131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: CKD-828
DRUG: Combination Therapy

Sponsor

Chong Kun Dang Pharmaceutical